摘要
近年来,我国在心血管疾病防控,治疗,科研和技术应用等方面取得了长足进步,但医疗服务能力和质量安全仍面临挑战:(1)心血管病医疗资源总量不断增长,已达到或接近发达国家水平,但配置不均的情况依然存在;(2)先进诊疗技术快速推广,但机构间应用规模和患者预后差异明显,对质量监管提出新要求;(3)部分疾病的诊疗流程持续改善,但距离质量改进目标和国际先进水平仍有明显差距,且有待应用到其他领域和基层医院;(4)院内死亡率等处于较低水平,但异质性依然突出,且需要引入非医嘱离院和再住院等全面评价。总的来说,心血管病医疗质量控制与改进工作任重道远,需要从工作组织体系,监测评价机制,改进干预行动等方面扎实推进,以持续改进医疗质量安全,提升医疗服务同质化,增强患者就医获得感。
China has made great progress in cardiovascular disease prevention,treatment,scientific research,and technological application in recent years,however,medical service capabilities and quality are still facing challenges:(1)Regional configuration difference still exists when the total amount of cardiovascular disease medical resources have continued to increase,which has been close to the developed countries;(2)Advanced diagnosis and treatment technology is rapidly promoted,but the scale of application and patient prognosis between institutions are significantly different,requiring more medical quality supervision;(3)The diagnosis and treatment process for some diseases continues to improve,but there is still a long distance from the quality improvement target,which should be applied in other cardiovascular diseases,popularized in primary hospitals;(4)Although the in-hospital mortality rate is low,the heterogeneity is significant.Non-doctoral discharge and readmission treatment should be included as evaluation index.In general,there is a long way for medical quality control and improvement of the cardiovascular diseases.For continuously improving the medical quality,the homogeneity of medical services,and patient satisfaction,organization system,monitoring and evaluation mechanism,and quality intervention actions need to be strengthened.
出处
《中国循环杂志》
CSCD
北大核心
2021年第11期1041-1064,共24页
Chinese Circulation Journal
关键词
心血管疾病
医疗资源
医疗服务能力
医疗质量
质控指标
cardiovascular disease
medical resources
medical service capabilities
medical quality
quality control indicators